Investment Summary

Avante Capital Partners Invests In Uncle John’s

On November 6, 2023, mezzanine finance firm Avante Capital Partners invested in food company Uncle John’s

Investment Highlights
  • This is Avante Capital Partners’ 3rd transaction in the Food sector.
  • This is Avante Capital Partners’ 42nd transaction in the United States.
  • This is Avante Capital Partners’ 3rd transaction in Florida.

Investment Summary

Date 2023-11-06
Target Uncle John’s
Sector Food
Investor(s) Avante Capital Partners
Deal Type Stake Purchase

Target

Uncle John’s

Tampa, Florida, United States
Uncle John’s is a producer of premium smoked sausages and meats. Offering a variety of fresh and smoked sausages through both retail and foodservice channels, the company features brand-named products under the banners of Uncle John’s Pride, Bean Brothers, Garcia Brand, Peppino Foods, Realtree and Zummo Meat. Uncle John’s was formed in 1974 and is headquartered in Tampa, Florida.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Avante Capital Partners

Los Angeles, California, United States

Investor Investor Investor Investor Investor


Category Mezzanine Finance Firm
Founded 2009
Size Small
Type Sector Agnostic
DESCRIPTION

Avante Mezzanine Partners is a provider of junior capital to lower middle-market companies generating at least $3 million in cash flow. The Firm looks to invest $5 to $20 million per transaction and generally works with private equity and independent sponsors in buyout transactions, as well as with entrepreneurs and owners to finance recapitalizations, refinancings, acquisitions and growth. Avante Mezzanine was formed in 2009 and has offices in Los Angeles and Boston.


DEAL STATS #
Overall 42 of 50
Sector: Food M&A 3 of 3
Type: Stake Purchase M&A Deals 3 of 3
State: Florida M&A 3 of 3
Country: United States M&A 42 of 50
Year: 2023 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-21 Monroe Biomedical Research

Monroe, North Carolina, United States

Monroe Biomedical Research offers a wide range of clinical trials, including investigations into treatments for pulmonary, metabolic, cardiological, psychiatric, and infectious diseases, as well as vaccine studies. Monroe Biomedical Research was founded in 2015 and is based in Monroe, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-31 Radsource

Brentwood, Tennessee, United States

Radsource provides clinical excellence in subspecialized musculoskeletal and neurological MRI interpretation. The company leverages its deep experience as radiologists and daily PACS users to deliver PACS solutions, ProtonPACS, to hospitals, imaging centers, physician practices, and various other medical imaging environments. Radsource was founded in 2002 and is based in Brentwood, Tennessee.

Buy -